(2,6-diethynyl-5a-methyl-2-propanoyloxy-3,3a,3b,4,5,7,8,8a,8b,9,10,10a-dodecahydro-1H-indeno[5,4-e]inden-6-yl) propanoate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (2,6-diethynyl-5a-methyl-2-propanoyloxy-3,3a,3b,4,5,7,8,8a,8b,9,10,10a-dodecahydro-1H-indeno[5,4-e]inden-6-yl) propanoate
• 化学式: C₂₇H₃₆O₄
• 分子量: 424.6
• InChiKey: JJKGZDJEKZMGTD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.3
• 重原子数：
  31
• 可旋转键数：
  8
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• Anordrin compositions and methods for treating diseases
  申请人：Shanghai Institute of Planned Parenthood Research

  公开号：US10231978B2

  公开（公告）日：2019-03-19

  The present invention provides methods and compositions for treating cancer, reducing side effects, and reducing postmenopausal symptoms comprising anordrin or analog thereof (such as anordrin) alone or in combination with at least one other agent selected from the group consisting of tamoxifen, raloxifene or functional equivalent thereof, and an aromatase inhibitor.

  本发明提供了用于治疗癌症、减少副作用和减轻绝经后症状的方法和组合物，这些方法和组合物包含单独使用或与至少一种选自他莫昔芬、雷洛昔芬或其功能等效物和芳香化酶抑制剂组成的组的其他制剂联合使用的安诺地林或其类似物（如安诺地林）。
• ANORDRIN COMPOSITIONS AND METHODS FOR TREATING DISEASES
  申请人：Shanghai Institute of Planned Parenthood Research

  公开号：US20170151263A1

  公开（公告）日：2017-06-01

  The present invention provides methods and compositions for treating cancer, reducing side effects, and reducing postmenopausal symptoms comprising anordrin or analog thereof (such as anordrin) alone or in combination with at least one other agent selected from the group consisting of tamoxifen, raloxifene or functional equivalent thereof, and an aromatase inhibitor.